Phase Ib/II Study of Pembrolizumab with Lanreotide Depot for Gastroenteropancreatic Neuroendocrine Tumors (PLANET)

Administered By

Awarded By

Contributors

Start/End

  • April 29, 2017 - March 31, 2022